Raghuram Selvaraju Downgraded (XRAY) to Hold on, Nov 30th, 2017
Raghuram has made no other calls on XRAY in the last 4 months.
There are 3 other peers that have a rating on XRAY. Out of the 3 peers that are also analyzing XRAY, 0 agree with Raghuram's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Raghuram
- Jonathan Block of "Stifel" Maintained at Strong Buy with Increased Target to $70 on, Monday, November 6th, 2017
- Michael Petusky of "Barrington Research" Upgraded from Hold to Buy on, Monday, November 6th, 2017
- Steve Beuchaw of "Morgan Stanley" Maintained at Buy with Increased Target to $69 on, Friday, October 6th, 2017
on: Mon, Nov 06th 2017
by: WOPRAI
on: Mon, Nov 06th 2017
by: WOPRAI
Jonathan Block Maintained (XRAY) at Strong Buy with Increased Target to $70 on, Nov 6th, 2017
on: Mon, Nov 06th 2017
by: WOPRAI
on: Tue, Feb 21st 2017
by: WOPRAI
Michael Petusky Downgraded (XRAY) to Hold on, Feb 21st, 2017
on: Wed, Nov 29th 2017
by: WOPRAI
on: Mon, Nov 27th 2017
by: WOPRAI
Mark Palmer Downgraded (SQ) to Strong Sell on, Nov 27th, 2017
on: Tue, Nov 21st 2017
by: WOPRAI
Timothy Willi Initiated (SQ) at Hold and Held Target at $42 on, Nov 21st, 2017
on: Mon, Nov 20th 2017
by: WOPRAI
Paul Condra Maintained (SQ) at Hold with Increased Target to $37 on, Nov 20th, 2017
on: Fri, Nov 17th 2017
by: WOPRAI
on: Thu, Nov 16th 2017
by: WOPRAI
Dan Dolev Maintained (SQ) at Strong Buy with Increased Target to $48 on, Nov 16th, 2017
on: Wed, Nov 15th 2017
by: WOPRAI
Aaron Rakers Initiated (AAPL) at Hold and Held Target at $49 on, Nov 15th, 2017
on: Wed, Nov 15th 2017
by: WOPRAI
Savanthi Syth Upgraded (ALK) to Strong Buy on, Nov 15th, 2017